Effective with date of service Feb. 23, 2023, Medicaid and NC Health Choice cover bendamustine hydrochloride injection, for intravenous use (Apotex).
Blog Entry List
Effective with date of service March 7, 2023, NC Medicaid and NC Health Choice programs cover aprepitant injectable emulsion.
Effective with date of service Jan. 27, 2023, Medicaid and NC Health Choice cover lenacapavir injection
Effective with date of service Jan. 30, 2023, the Medicaid and NC Health Choice programs cover bendamustine hydrochloride injection, for intravenous use (Baxter).
Effective with date of service Jan. 27, 2023, the Medicaid and NC Health Choice programs covers ublituximab-xiiy injection, for intravenous use (Briumvi)
Pegfilgrastim-FpgkInjection, for Subcutaneous Use (Stimufend®) HCPCS Code J3590 - Billing Guidelines
Effective with date of service Jan. 23, 2023, the Medicaid and NC Health Choice programs cover pegfilgrastim-fpgk
Effective with date of service Jan. 20, 2023, the Medicaid and NC Health Choice programs cover fecal microbiota, live - jslm suspension, for rectal use (Rebyota).
Effective with date of service, Dec. 21, 2022, the NC Medicaid and NC Health Choice programs cover piflufolastat F18 injection
As of April 1, 2023, all NC Health Choice beneficiaries with active eligibility will be moved to Medicaid.
Effective Dec. 7, 2022, Medicaid and NC Health Choice cover bendamustine hydrochloride injection, for intravenous use (Vivimusta).
Effective Jan. 9, 2023, Medicaid and NC Health Choice cover mosunetuzumab-axgb injection, for intravenous use (Lunsumio).
Effective Dec. 1, 2022, Medicaid and NC Health Choice cover teplizumab-mzwv injection.
Effective Dec. 15, 2022, Medicaid and NC Health Choice cover mirvetuximab soravtansine-gynx injection.
Effective Nov. 16, 2022, Medicaid and NC Health Choice cover tremelimumab-actl injection.
Note: This bulletin is replaced by NC Health Choice Move to Medicaid: Timeline for Claims Adjudication and Process for Prior Approvals.